trending Market Intelligence /marketintelligence/en/news-insights/trending/4ngtohrndyqnfntuxbfhpa2 content esgSubNav
In This List

Silence Therapeutics CEO steps down

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Silence Therapeutics CEO steps down

London-based Silence Therapeutics PLC said June 4 that Ali Mortazavi stepped down as CEO and as a director of the company.

Annalisa Jenkins, the company's nonexecutive chair, was appointed executive chair until a new CEO is appointed.

Silence Therapeutics develops and sells RNA therapies for treating cancer, heart disease and metabolic diseases, among others.